HomeProductsBioactive CompoundsNeuronal Signaling5-HT ReceptorCAS 148372-04-7
Chemical structure of CAS 148372-04-7

(3E)-3-((2,4-Dimethoxyphenyl)methylene)-3,4,5,6-tetrahydro-2,3'-bipyridine

CAS No.148372-04-7
MDL No.MFCD00941364
MFC19H20N2O2
MW308.40
InChI KeyRPYWXZCFYPVCNQ-RVDMUPIBSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

DMXB-A is a dimethoxybenzene.

CAS No.148372-04-7
Product Name(3E)-3-((2,4-Dimethoxyphenyl)methylene)-3,4,5,6-tetrahydro-2,3'-bipyridine

Biological Targets

CHRNA7

Associated Conditions

nicotine dependence·obesity·autism·schizoaffective disorder·Alzheimer disease·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Therapeutic potential of α7 nicotinic acetylcholine receptor agonists to combat obesity, diabetes, and inflammation.

Reviews in endocrine & metabolic disorders • Vol. 21, Issue 4 • 2020
PMID: 32851581PMC: PMC7572644DOI: 10.1007/s11154-020-09584-3

GTS-21 has cell-specific anti-inflammatory effects independent of α7 nicotinic acetylcholine receptors.

PloS one • Vol. 14, Issue 4 • 2019
PMID: 30947238PMC: PMC6448884DOI: 10.1371/journal.pone.0214942

Discovery of the alpha7 nicotinic acetylcholine receptor agonists. (R)-3'-(5-Chlorothiophen-2-yl)spiro-1-azabicyclo[2.2.2]octane-3,5'-[1',3']oxazolidin-2'-one as a novel, potent, selective, and orally bioavailable ligand.

Journal of medicinal chemistry • Vol. 48, Issue 7 • 2005
PMID: 15801858DOI: 10.1021/jm049188d

Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia.

Psychopharmacology • Vol. 174, Issue 1 • 2004
PMID: 15205879DOI: 10.1007/s00213-003-1750-1

Documentation